EOLS: Evolus Inc Company Profile & Statistics

About

Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.

Info & Links

CEO

David Moatazedi

Headquarters

520 Newport Center Dr., Suite 1200
Newport Beach, CA 92660, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

273

Evolus Inc Statistics

Valuation Measures

Market Capitalization²

721.85M

Enterprise Value

758.02M

Enterprise Value/EBITDA(ttm)

-22.50

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.93

Price to Book(mrq)

123.30

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

69.90%

Operating Margin(ttm)

-19.59%

Profit Margin(ttm)

-22.46%

Return on Equity(ttm)

-847.60%

Return on Invested Capital(ttm)

-44.47%

Return on Assets(ttm)

-22.15%

Income Statement

Revenue(ttm)

248.33M

Revenue Per Share(ttm)

3.92

Gross Profit(ttm)

173.69M

EBITDA(ttm)³

-33.69M

Net Income Available to Common(ttm)

-55.46M

Diluted EPS(ttm)

-0.91

Share Statistics

Beta (5Y Monthly)

1.27

52-Week Change

15.21%

S&P 500 52-Week Change

26.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

63.32M

Dividend Yield

0.00%

Float⁴

59.46M

% Held by Insiders

6.10%

% Held by Institutions

90.69%

Balance Sheet

Total Cash(mrq)

85.03M

Total Cash Per Share(mrq)

1.34

Total Debt(mrq)

121.21M

Total Debt/Equity(mrq)

2057.86%

Current Ratio(mrq)

2.47%

Quick Ratio(mrq)

2.23%

Book Value Per Share(mrq)

0.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.36

Free Cash Flow(ytd)

-26.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EOLS

Evolus Inc

Evolus Inc Profile